Vestibular Function and Vertigo Control after Intratympanic Gentamicin for Ménière’s Disease | Zendy

Kimanh D. Nguyen | Zendy; Lloyd B. Minor | Zendy; Charles C. Della Santina | Zendy; John P. Carey | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Vestibular Function and Vertigo Control after Intratympanic Gentamicin for Ménière’s Disease

Author(s) -

Kimanh D. Nguyen,

Lloyd B. Minor,

Charles C. Della Santina,

John P. Carey

Publication year - 2009

Publication title -

audiology and neurotology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.106

H-Index - 78

eISSN - 1421-9700

pISSN - 1420-3030

DOI - 10.1159/000241893

Subject(s) - vertigo , medicine , meniere's disease , vestibular system , nystagmus , vestibulo–ocular reflex , caloric theory , gentamicin , reflex , weakness , surgery , audiology , anesthesia , antibiotics , chemistry , biochemistry

The aim of this study was to correlate long-term vertigo control with reduction in vestibular function after intratympanic (IT) gentamicin therapy for unilateral Ménière's disease. IT gentamicin injections were given as needed to control vertigo attacks. Vertigo frequency and changes in angular vestibulo-ocular reflex (AVOR) gain (measured using magnetic search coils and manual head thrusts) and caloric weakness were assessed before and after treatment. Better vertigo control after treatment was found with >or=60% reduction in quantitative ipsilateral horizontal semicircular canal AVOR gain from pre-treatment values and/or with caloric unilateral weakness (UW) >50%. However, no correlations were found between the continuous variables of vertigo control and either gain or gain recovery, nor between gain and UW because of the large variability in vertigo control in subjects with lesser reductions in these measures.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research